A pilot study of hormone replacement therapy with tibolone in women with mastopathic breasts

Maturitas

Volumn 40, Issue 2, 2001, Pages 165-171

  Egarter, Christian ^a   Eppel, Wolfgang ^a   Vogel, Sonja ^a   Wolf, Georg ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Postmenopausal women; Prospective randomized double blind pilot study; Tibolone

Indexed keywords

ESTRADIOL; FOLLITROPIN; TIBOLONE;

ARTICLE; BODY WEIGHT; BREAST DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE SUBSTITUTION; HORMONE SYNTHESIS; HUMAN; MAMMOGRAPHY; PARITY; PILOT STUDY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SMOKING; TREATMENT OUTCOME;

BREAST; DOUBLE-BLIND METHOD; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MAMMOGRAPHY; MIDDLE AGED; NORPREGNENES; PILOT PROJECTS; POSTMENOPAUSE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0035976489     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(01)00235-3     Document Type: Article

References (14)

1. The variation of breast parenchymal pattern with age
2. Hormonal replacement therapy: Mammographic manifestations
3. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern
4. Breast mammographic pattern: A concatenation of confounding and breast cancer risk factors
5. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: A case-control study
6. Efficacy, tolerability, and rare side effects of tibolone treatment in a large collective of postmenopausal women
7. Mammographic changes in women receiving tibolone therapy
8. Mammographic densities and risk of breast cancer
9. Mammographic breast density during hormone replacement therapy: Differences according to treatment
10. Breast cancer and HRT: Collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
11. Tibolone and its metabolites: Pharmacology, tissue specificity, and effects in animal models of tumors
12. Control of estrone sulfatase activity in human breast cancer cells
13. Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells
14. The effect of tibolone on proliferation, differentiation, and apoptosis in normal breast cells